Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L

G W Dorn1, L A Kirshenbaum

  • 1Department of Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St Louis, MO 63110, USA.

Oncogene
|July 31, 2009
PubMed

Insights

Programmed cell death in heart muscle is crucial for understanding heart disease progression. This review focuses on BNIP3 and NIX/BNIP3L proteins and their roles in cardiac remodeling and cell death.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cell Death Mechanisms

Background:

  • Programmed cardiac myocyte death drives pathological ventricular remodeling.
  • This process contributes to the progression of myocardial infarction and pressure overload hypertrophy to dilated cardiomyopathy.
  • Stress-mediated transcriptional induction of BNIP3 and NIX/BNIP3L is critical in cardiac remodeling.

Purpose of the Study:

  • To review the regulatory mechanisms of BNIP3 and NIX/BNIP3L in the heart.
  • To examine the effects of these factors on programmed cardiomyocyte death.
  • To synthesize findings from mouse models of cardiac BNIP3 and NIX/BNIP3L manipulation.

Main Methods:

  • Literature review of studies on cardiac BNIP3 and NIX/BNIP3L.
  • Analysis of data from mouse models with gene overexpression.
  • Evaluation of results from mouse models with gene ablation.

Main Results:

  • BNIP3 and NIX/BNIP3L are key regulators of stress-induced cardiac remodeling.
  • Overexpression and ablation studies in mice reveal specific roles in cardiomyocyte death.
  • These proteins influence the transition from hypertrophy to dilated cardiomyopathy.

Conclusions:

  • BNIP3 and NIX/BNIP3L are critical mediators of programmed cardiomyocyte death.
  • Understanding their regulation is vital for targeting pathological cardiac remodeling.
  • Further research in mouse models will elucidate therapeutic strategies for heart failure.